The Forward on MSN
Conservative rabbinical school Ziegler stops admissions, signaling broader overhaul
The Ziegler School of Rabbinical Studies will not be admitting new students in the upcoming academic year, it told current ...
MIT alumni are helping build a better MBTA— reshaping route planning, improving service, and supporting the workforce that ...
U.S. FDA Fast Track designation granted to AKY-11891 for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have progressed on or after prior systemic ...
Regenerative Medicine Advanced Therapy (RMAT) designation requests update submitted to FDA with recent biomarker data ...
Cutting SaaS licenses may save money fast, but without clear ownership and process, you’ll just trade spend for chaos.
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
Navios Maritime Partners L.P. (NYSE:NMM) Q4 2025 Earnings Call Transcript February 19, 2026 Navios Maritime Partners L.P. beats earnings expectations. Reported EPS is $3.4, expectations were $1.96.
Grand Canyon Education, Inc. (NASDAQ:LOPE) Q4 2025 Earnings Call Transcript February 18, 2026 Grand Canyon Education, Inc. beats earnings expectations. Reported EPS is $3.21, expectations were $3.19.
Morning Overview on MSN
US molten salt reactors leap forward as new nuclear fuel clears key hurdle
Idaho National Laboratory has produced what the Department of Energy describes as the first batch of fuel for the world’s first fast-spectrum molten salt reactor, clearing one of the longest-standing ...
Straight Arrow News on MSN
Glove DNA may link suspect in Guthrie case; 1,000 ICE agents leave Minnesota
Watch now: DNA from a glove may link a suspect in the Guthrie case. Plus, Tom Homan confirms 1,000 immigration agents have left Minnesota.
Andrea Brochu, mother of an 18-year-old, testifies at the SB 498 hearing about the need for private insurance to cover children's behavioral services Credit: Courtesy - New Futures Sign up for the ...
WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results